Harnessing Corneal Stromal Regeneration for Vision Restoration: A Comprehensive Review of the Emerging Treatment Techniques for Keratoconus

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Oct 22

PMID 39435192

Authors

Zoya Javed

Sachin Daigavane

Affiliations

Soon will be listed here.

Abstract

Keratoconus is a progressive corneal disorder characterized by thinning and conical protrusion, leading to visual impairment that often necessitates advanced treatment strategies. Traditional management options, including corrective lenses, corneal cross-linking (CXL), and surgical interventions such as corneal transplants and intracorneal ring segments (ICRS), address symptoms but have limitations, especially in progressive or advanced cases. Recent advancements in corneal stromal regeneration offer promising alternatives for enhancing vision restoration and halting disease progression. This review explores emerging techniques focused on corneal stromal regeneration, emphasizing cell-based therapies, tissue engineering, and gene therapy. Cell-based approaches, including corneal stromal stem cells and adipose-derived stem cells, are promising to promote tissue repair and functional recovery. Tissue engineering techniques, such as developing synthetic and biological scaffolds and 3D bioprinting, are being investigated for their ability to create viable corneal grafts and implants. Additionally, gene therapy and molecular strategies, including gene editing technologies and the application of growth factors, are advancing the potential for targeted treatment and regenerative medicine. Despite these advancements, challenges remain, including technical limitations, safety concerns, and ethical considerations. This review aims to provide a comprehensive overview of these innovative approaches, highlighting their current status, clinical outcomes, and future directions in keratoconus management.

References

Espana E, Birk D . Composition, structure and function of the corneal stroma. Exp Eye Res. 2020; 198:108137. PMC: 7508887. DOI: 10.1016/j.exer.2020.108137. View

Gcabashe N, Moodley V, Hansraj R . Prevalence and clinical profile of keratoconus in patients presenting at a provincial hospital in KwaZulu, Natal, South Africa: A case study. J Public Health Afr. 2023; 14(9):2356. PMC: 10628798. DOI: 10.4081/jphia.2023.2356. View

Holland G, Pandit A, Sanchez-Abella L, Haiek A, Loinaz I, Dupin D . Artificial Cornea: Past, Current, and Future Directions. Front Med (Lausanne). 2021; 8:770780. PMC: 8632951. DOI: 10.3389/fmed.2021.770780. View

McNair L . Ethical and regulatory oversight of clinical research: The role of the Institutional Review Board. Exp Biol Med (Maywood). 2022; 247(7):561-566. PMC: 9014527. DOI: 10.1177/15353702221078216. View

Ahadi M, Ramin S, Abbasi A, Tahmouri H, Hosseini S . Mini review: human clinical studies of stem cell therapy in keratoconus. BMC Ophthalmol. 2024; 24(1):35. PMC: 10804477. DOI: 10.1186/s12886-024-03297-w. View

Han F, Wang J, Ding L, Hu Y, Li W, Yuan Z . Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia. Front Bioeng Biotechnol. 2020; 8:83. PMC: 7105900. DOI: 10.3389/fbioe.2020.00083. View

Goetz L, Schork N . Personalized medicine: motivation, challenges, and progress. Fertil Steril. 2018; 109(6):952-963. PMC: 6366451. DOI: 10.1016/j.fertnstert.2018.05.006. View

Kalamajski S, Oldberg A . The role of small leucine-rich proteoglycans in collagen fibrillogenesis. Matrix Biol. 2010; 29(4):248-53. DOI: 10.1016/j.matbio.2010.01.001. View

Meek K, Knupp C . Corneal structure and transparency. Prog Retin Eye Res. 2015; 49:1-16. PMC: 4655862. DOI: 10.1016/j.preteyeres.2015.07.001. View

10.

Mansoor H, Ong H, Riau A, Stanzel T, Mehta J, Yam G . Current Trends and Future Perspective of Mesenchymal Stem Cells and Exosomes in Corneal Diseases. Int J Mol Sci. 2019; 20(12). PMC: 6627168. DOI: 10.3390/ijms20122853. View

11.

Farjadnia M, Naderan M, Mohammadpour M . Gene therapy in keratoconus. Oman J Ophthalmol. 2015; 8(1):3-8. PMC: 4333540. DOI: 10.4103/0974-620X.149854. View

12.

Khanna A, Zamani M, Huang N . Extracellular Matrix-Based Biomaterials for Cardiovascular Tissue Engineering. J Cardiovasc Dev Dis. 2021; 8(11). PMC: 8622600. DOI: 10.3390/jcdd8110137. View

13.

Mohammadpour M, Masoumi A, Mirghorbani M, Shahraki K, Hashemi H . Updates on corneal collagen cross-linking: Indications, techniques and clinical outcomes. J Curr Ophthalmol. 2017; 29(4):235-247. PMC: 5735256. DOI: 10.1016/j.joco.2017.07.003. View

14.

Ahuja A . The impact of artificial intelligence in medicine on the future role of the physician. PeerJ. 2019; 7:e7702. PMC: 6779111. DOI: 10.7717/peerj.7702. View

15.

Schork N . Artificial Intelligence and Personalized Medicine. Cancer Treat Res. 2019; 178:265-283. PMC: 7580505. DOI: 10.1007/978-3-030-16391-4_11. View

16.

Yu F, Yin J, Xu K, Huang J . Growth factors and corneal epithelial wound healing. Brain Res Bull. 2009; 81(2-3):229-35. PMC: 3010187. DOI: 10.1016/j.brainresbull.2009.08.024. View

17.

Uddin F, Rudin C, Sen T . CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future. Front Oncol. 2020; 10:1387. PMC: 7427626. DOI: 10.3389/fonc.2020.01387. View

18.

Volatier T, Cursiefen C, Notara M . Current Advances in Corneal Stromal Stem Cell Biology and Therapeutic Applications. Cells. 2024; 13(2). PMC: 10814767. DOI: 10.3390/cells13020163. View

19.

Wu D, Lim D, Lim B, Wong N, Hafezi F, Manotosh R . Corneal Cross-Linking: The Evolution of Treatment for Corneal Diseases. Front Pharmacol. 2021; 12:686630. PMC: 8326410. DOI: 10.3389/fphar.2021.686630. View

20.

Liang J, Liu P, Yang X, Liu L, Zhang Y, Wang Q . Biomaterial-based scaffolds in promotion of cartilage regeneration: Recent advances and emerging applications. J Orthop Translat. 2023; 41:54-62. PMC: 10485599. DOI: 10.1016/j.jot.2023.08.006. View